Stappers F - Search Results

1

Soluble adenylyl cyclase (sAC) regulates calcium signaling in the vascular endothelium.

Mewes M, Lenders M, Stappers F, Scharnetzki D, Nedele J, Fels J, Wedlich-Söldner R, Brand SM, Schmitz B, Brand E. Mewes M, et al. Among authors: stappers f. FASEB J. 2019 Dec;33(12):13762-13774. doi: 10.1096/fj.201900724R. Epub 2019 Oct 4. FASEB J. 2019. PMID: 31585052

2

Mutation-specific Fabry disease patient-derived cell model to evaluate the amenability to chaperone therapy.

Lenders M, Stappers F, Niemietz C, Schmitz B, Boutin M, Ballmaier PJ, Zibert A, Schmidt H, Brand SM, Auray-Blais C, Brand E. Lenders M, et al. Among authors: stappers f. J Med Genet. 2019 Aug;56(8):548-556. doi: 10.1136/jmedgenet-2019-106005. Epub 2019 Apr 22. J Med Genet. 2019. PMID: 31010832

3

Neutralising anti-drug antibodies in Fabry disease can inhibit endothelial enzyme uptake and activity.

Stappers F, Scharnetzki D, Schmitz B, Manikowski D, Brand SM, Grobe K, Lenders M, Brand E. Stappers F, et al. J Inherit Metab Dis. 2020 Mar;43(2):334-347. doi: 10.1002/jimd.12176. Epub 2019 Nov 14. J Inherit Metab Dis. 2020. PMID: 31587315

4

Detailed epitope mapping of neutralizing anti-drug antibodies against recombinant α-galactosidase A in patients with Fabry disease.

Scharnetzki D, Stappers F, Lenders M, Brand E. Scharnetzki D, et al. Among authors: stappers f. Mol Genet Metab. 2020 Sep-Oct;131(1-2):229-234. doi: 10.1016/j.ymgme.2020.08.005. Epub 2020 Aug 28. Mol Genet Metab. 2020. PMID: 32888778

5

In Vitro and In Vivo Amenability to Migalastat in Fabry Disease.

Lenders M, Stappers F, Brand E. Lenders M, et al. Among authors: stappers f. Mol Ther Methods Clin Dev. 2020 Aug 20;19:24-34. doi: 10.1016/j.omtm.2020.08.012. eCollection 2020 Dec 11. Mol Ther Methods Clin Dev. 2020. PMID: 32995357 Free PMC article. Review.

6

RORγt inhibition ameliorates IL-23 driven experimental psoriatic arthritis by predominantly modulating γδ-T cells.

Mortier C, Gracey E, Coudenys J, Manuello T, Decruy T, Maelegheer M, Stappers F, Gilis E, Gaublomme D, Van Hoorebeke L, Van Welden S, Ambler C, Hegen M, Symanowicz P, Steyn S, Berstein G, Elewaut D, Venken K. Mortier C, et al. Among authors: stappers f. Rheumatology (Oxford). 2023 Sep 1;62(9):3169-3178. doi: 10.1093/rheumatology/kead022. Rheumatology (Oxford). 2023. PMID: 36661300

7

Development of a long-acting injectable formulation with nanoparticles of rilpivirine (TMC278) for HIV treatment.

Baert L, van 't Klooster G, Dries W, François M, Wouters A, Basstanie E, Iterbeke K, Stappers F, Stevens P, Schueller L, Van Remoortere P, Kraus G, Wigerinck P, Rosier J. Baert L, et al. Among authors: stappers f. Eur J Pharm Biopharm. 2009 Aug;72(3):502-8. doi: 10.1016/j.ejpb.2009.03.006. Epub 2009 Mar 27. Eur J Pharm Biopharm. 2009. PMID: 19328850

8

Starch-based microspheres produced by emulsion crosslinking with a potential media dependent responsive behavior to be used as drug delivery carriers.

Malafaya PB, Stappers F, Reis RL. Malafaya PB, et al. Among authors: stappers f. J Mater Sci Mater Med. 2006 Apr;17(4):371-7. doi: 10.1007/s10856-006-8240-z. J Mater Sci Mater Med. 2006. PMID: 16617416 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

8 results

Search Page